Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients

Lozano, Roberto; Me, Franco; Lopez, Luis; Jj, Moneva; Carrasco, J.A.; Ma, Pérez-Layo

doi:10.5414/cp202206

2015

DOI: 10.5414/cp202206

|View full text |Cite

Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients

Roberto Lozano¹,

Franco Me²,

Luis Lopez³

et al.

Abstract: VKORC1 A and CYP2C92 and/or 3 allelic variants extremely influence on AC dose requirement of highly sensitive geriatric patients. These patients display acenocoumarol dose requirement of ≤5.6 mg/week.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients

Abstract: VKORC1 A and CYP2C92 and/or 3 allelic variants extremely influence on AC dose requirement of highly sensitive geriatric patients. These patients display acenocoumarol dose requirement of ≤5.6 mg/week.

This publication either has no citations yet, or we are still processing them

See others like this or search for similar articles

Contact Info

Product

Resources

About

Genotype-based dosage of acenocoumarol in highly-sensitive geriatric patients

Abstract: VKORC1 A and CYP2C9*2 and/or *3 allelic variants extremely influence on AC dose requirement of highly sensitive geriatric patients. These patients display acenocoumarol dose requirement of ≤5.6 mg/week.

This publication either has no citations yet, or we are still processing them

See others like this or search for similar articles

Contact Info

Product

Resources

About

Abstract: VKORC1 A and CYP2C92 and/or 3 allelic variants extremely influence on AC dose requirement of highly sensitive geriatric patients. These patients display acenocoumarol dose requirement of ≤5.6 mg/week.